PAG
SLS icon

Private Advisor Group’s SELLAS Life Sciences SLS Stock Holding History

Private Advisor Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$82.7K Buy
19,540
+1,335
+7% +$5.97K ﹤0.01% 2545
2025
Q4 		$68.6K Buy
+18,205
New +$35.4K ﹤0.01% 2503

Other funds holding SLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Private Advisor Group's SLS Position: Q1 2026 in Review

Private Advisor Group increased its SELLAS Life Sciences (SLS) stake by 7.3% in Q1 2026, buying an estimated $5.97K and bringing the position to 19,540 shares worth $82.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2545.

Private Advisor Group first reported a position in SLS in Q4 2025 and has held it in 2 quarters since. 160 funds tracked by Wall St. Rank hold SLS as of Q1 2026.

  • Private Advisor Group held 19,540 shares of SELLAS Life Sciences worth $82.7K as of Q1 2026.
  • Private Advisor Group bought 1,335 SELLAS Life Sciences shares in Q1 2026, an estimated $5.97K.
  • SELLAS Life Sciences made up ﹤0.01% of Private Advisor Group's portfolio in Q1 2026, its #2545 holding.
  • Private Advisor Group first reported a position in SELLAS Life Sciences in Q4 2025 and has held it in 2 quarters since.
  • 160 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.